Accuray is reporting revenue increases for its third quarter 2023.
The company's net revenue for the quarter (end-March 31) was $118.1 million, up 22.8% compared to $96.2 million during the same period last year. Accuray posted net income of $600,000, compared with a net loss of $1 million in the third quarter of 2022.
For the nine-month period, Accuray posted net revenue of $329.3 million, up from $319.9 million for the same period last year. Net loss for the nine months was $6.7 million compared with a net loss of $1.9 million in 2022.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
